Dott.ssa Luisa Gilardini

1991
Maturità classica. 

1997
Laurea in Medicina e Chirurgia (110/110 e lode) presso l’Università degli Studi di Milano.

2000
Specializzazione (cum laude) in Endocrinologia Sperimentale.

2007
Specializzazione (cum laude) in Medicina Interna.

Si occupa prevalentemente di diabete, obesità dell’adulto ed infantile, dislipidemia e sindrome metabolica. Svolge inoltre visite di medicina interna. 

Ha da sempre svolto ricerca clinica sulla fisiopatologia del diabete di tipo 2, le complicanze metaboliche e cardiovascolari nell'obesità adulta ed infantile, l’effetto di diversi interventi terapeutici sullo stile di vita o farmacologici nel prevenire le complicanze cardio-metaboliche. Partecipa anche a ricerche di base sul ruolo del tessuto adiposo sullo sviluppo di complicanze cardio-metaboliche.

Autore di  lavori su peer reviewed Journals e numerose presentazioni a congressi internazionali e nazionali. 

Selezione di alcune pubblicazioni: 

Invitti C., Guzzaloni G., Gilardini L., Morabito F., Viberti G.: Prevalence and concomitans of glucose intolerance  in European obese children and adolescents. Diabetes Care 2003, 26; 118-24.
Invitti C., Gilardini L., Viberti G.C. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;351:1146-48. 
Gilardini L, McTernan PG, Girola A, da Silva NF, Alberti L, Kumar S, Invitti C. Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. Atherosclerosis, 2006, 189: 401-07. 
Invitti C, Giardini L, Pontiggia B, Morabito F, Mazzilli G, Viberti G Period prevalence of abnormal glucose tolerance and its concomitans in Italian obese children. NMCD 2006, 16:256-62. 
Invitti C., Maffeis C., Gilardini L., Pontiggia B., Mazzilli G., Morabito F., Viberti G.C. Metabolic sindrome in obese Caucasian children: prevalence using WHO-derived criteria and association with non traditional cardiovascular risk factors. Int J Obesity 2006, 30:627-633.
Alberti L, Gilardini L, Girola A, Moro M, Cavagnini F, Invitti C Adiponectin receptors gene expression in lymphocytes of obese and anorectic patients. Diabetes Obes Metab. 2007; 9:344-49.
Alberti L, Girola A, Gilardini L, Conti A, Cattaldo S, Micheletto G, Invitti C. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese  subjects. Int J Obes (Lond). 2007, 31: 1826-31.
L. Gilardini, G. Parati, A. Sartorio, G. Mazzilli, B. Pontiggia, C. Invitti. Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity. J Human Hypertension 2008, 22:75-82.
L. Alberti, L. Gilardini, A Zulian, G Micheletto, G Peri, A Doni, A Mantovani, C Invitti. Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors. Atherosclerosis, 2009; 202:4555-460.
Mantovani G, Bondioni S, Alberti L, Gilardini L, Invitti C, Corbetta S, Zappa MA, Ferrero S, Lania AG, Bosari S, Beck-Peccoz P, Spada A PKA regulatory subunits in human adipose tissue: decreased R2 B expression and activity in adipocytes from obese subjects. Diabetes 2009 ;58:620-26.
Gilardini L, Zulian A, Girola A, Redaelli G, Conti A, Invitti C Predictors of the early impairment of renal disease in human obesity. Int J Obes (Lond). 2010 Feb;34:287-94.
A. Zulian, R. Cancello, A. Girola, L.Gilardini, L.Alberti, M. Croci, G. Micheletto, P. Danelli, C. Invitti. In vivo and in vitro effects of metformin on adiponectin in human adipose tissue. Obesity facts 2011, 4 :27-33. 
L. Gilardini, L. Pasqualinotto, S. Di Matteo, K. Caffetto, M. Croci, A. Girola,  C. Invitti. Factors associated with early atherosclerosis and arterial calcifications in young subjects with a begnin phenotype of obesity. Obesity 2011; 19:1684-89.
Zulian A, Cancello R, Micheletto G, Gentilini D, Gilardini L, Danelli P, Invitti C Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease? Gut  2012; 61:86-94.
Gilardini L.,Vallone L., Cottafava R., Redaelli G., Croci M., Conti A., Pasqualinotto L., Invitti C. Insulin Sensitivity Deteriorates after Short-Term Lifestyle Intervention in the Insulin Sensitive Phenotype of Obesity. Obesity Facts 2012;5:68-76.
Mencarelli M., Zulian A., Cancello R., Alberti L., Gilardini L., Di Blasio AM., Invitti C. A novel missense mutation in the signal peptide of the human POMC gene is associated with obesity and early-onset diabetes. Eur J Hum Genet. 2012, 20:1290-4.
Gilardini L, Lombardi C, Redaelli G, Vallone L, Faini A, Mattaliano P, Parati G, Invitti C Glucose tolerance and weight loss in obese women with obstructive sleep apnea. PLoS One. 2013;8:e61382. 
Gilardini L, Croci M, Pasqualinotto l, Caffetto K, Invitti C .Dietary habits and cardiometabolic health in obese children, Obesity facts 2015;8:101-09.
Varma MC, Kusminski CM, Azharian S, Gilardini L, Kumar S, Invitti C, McTernan PG Metabolic endotoxaemia in childhood obesity. BMC Obes. 2016;3:3. eCollection 2015.
Gilardini L, Redaelli G, Croci M, Conti A, Pasqualinotto L, Invitti C. Effect of a Modest Weight Loss in Normalizing Blood Pressure in Obese Subjects on Antihypertensive Drugs. 
Obesity Facts. 2016;9:251
Gilardini L, Pasqualinotto L, Di Pierro F, Risso P, Invitti C. Effects of Greenselect Phytosome® on weight maintenance after weight loss in obese women: a 
randomized placebo-controlled study. BMC Complement Altern Med. 2016 22;16:23358.
 

È membro della Società Italiana di Diabetologia e della Società Italiana Obesità.